206 related articles for article (PubMed ID: 31589822)
1. Addressing the Challenge of Polypharmacy.
Mair A; Wilson M; Dreischulte T
Annu Rev Pharmacol Toxicol; 2020 Jan; 60():661-681. PubMed ID: 31589822
[TBL] [Abstract][Full Text] [Related]
2. Reducing inappropriate polypharmacy: the process of deprescribing.
Scott IA; Hilmer SN; Reeve E; Potter K; Le Couteur D; Rigby D; Gnjidic D; Del Mar CB; Roughead EE; Page A; Jansen J; Martin JH
JAMA Intern Med; 2015 May; 175(5):827-34. PubMed ID: 25798731
[TBL] [Abstract][Full Text] [Related]
3. Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments.
Stewart D; Mair A; Wilson M; Kardas P; Lewek P; Alonso A; McIntosh J; MacLure K;
Expert Opin Drug Saf; 2017 Feb; 16(2):203-213. PubMed ID: 27885844
[TBL] [Abstract][Full Text] [Related]
4. A narrative review of the safety concerns of deprescribing in older adults and strategies to mitigate potential harms.
Reeve E; Moriarty F; Nahas R; Turner JP; Kouladjian O'Donnell L; Hilmer SN
Expert Opin Drug Saf; 2018 Jan; 17(1):39-49. PubMed ID: 29072544
[TBL] [Abstract][Full Text] [Related]
5. Is my older cancer patient on too many medications?
Turner JP; Shakib S; Bell JS
J Geriatr Oncol; 2017 Mar; 8(2):77-81. PubMed ID: 27840102
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of polypharmacy in a Scottish primary care population.
Payne RA; Avery AJ; Duerden M; Saunders CL; Simpson CR; Abel GA
Eur J Clin Pharmacol; 2014 May; 70(5):575-81. PubMed ID: 24487416
[TBL] [Abstract][Full Text] [Related]
7. Impact of strategies to reduce polypharmacy on clinically relevant endpoints: a systematic review and meta-analysis.
Johansson T; Abuzahra ME; Keller S; Mann E; Faller B; Sommerauer C; Höck J; Löffler C; Köchling A; Schuler J; Flamm M; Sönnichsen A
Br J Clin Pharmacol; 2016 Aug; 82(2):532-48. PubMed ID: 27059768
[TBL] [Abstract][Full Text] [Related]
8. Frailty, polypharmacy and deprescribing.
Drug Ther Bull; 2016 Jun; 54(6):69-72. PubMed ID: 27284125
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing medications in older people: a narrative review.
Salahudeen MS
Drugs Today (Barc); 2018 Aug; 54(8):489-498. PubMed ID: 30209443
[TBL] [Abstract][Full Text] [Related]
10. GPs' management of polypharmacy and therapeutic dilemma in patients with multimorbidity: a cross-sectional survey of GPs in France.
Carrier H; Zaytseva A; Bocquier A; Villani P; Verdoux H; Fortin M; Verger P
Br J Gen Pract; 2019 Apr; 69(681):e270-e278. PubMed ID: 30803978
[TBL] [Abstract][Full Text] [Related]
11. Classic challenges and emerging approaches to medication therapy in older adults.
Alagiakrishnan K; Mah D; Padwal R
Discov Med; 2018 Oct; 26(143):137-146. PubMed ID: 30586537
[TBL] [Abstract][Full Text] [Related]
12. Deprescribing: A simple method for reducing polypharmacy.
McGrath K; Hajjar ER; Kumar C; Hwang C; Salzman B
J Fam Pract; 2017 Jul; 66(7):436-445. PubMed ID: 28700758
[TBL] [Abstract][Full Text] [Related]
13. General practitioners' views on polypharmacy and its consequences for patient health care.
Köberlein J; Gottschall M; Czarnecki K; Thomas A; Bergmann A; Voigt K
BMC Fam Pract; 2013 Aug; 14():119. PubMed ID: 23947640
[TBL] [Abstract][Full Text] [Related]
14. International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): Position Statement and 10 Recommendations for Action.
Mangin D; Bahat G; Golomb BA; Mallery LH; Moorhouse P; Onder G; Petrovic M; Garfinkel D
Drugs Aging; 2018 Jul; 35(7):575-587. PubMed ID: 30006810
[TBL] [Abstract][Full Text] [Related]
15. Polypharmacy in chronic diseases-Reduction of Inappropriate Medication and Adverse drug events in older populations by electronic Decision Support (PRIMA-eDS): study protocol for a randomized controlled trial.
Sönnichsen A; Trampisch US; Rieckert A; Piccoliori G; Vögele A; Flamm M; Johansson T; Esmail A; Reeves D; Löffler C; Höck J; Klaassen-Mielke R; Trampisch HJ; Kunnamo I
Trials; 2016 Jan; 17():57. PubMed ID: 26822311
[TBL] [Abstract][Full Text] [Related]
16. Appropriateness and surveillance of medication in a cohort of diabetic patients on polypharmacy.
Harder S; Saal K; Blauth E; Beyer M; Gerlach FM
Int J Clin Pharmacol Ther; 2009 Feb; 47(2):104-10. PubMed ID: 19203566
[TBL] [Abstract][Full Text] [Related]
17. [Impact of Geriatric Drug Guidelines on the Quality Requirement of Elderly Patients].
Fauvelle F; Kabirian F; Domingues A; Tubach F; Gault N; Abbas R
Therapie; 2015; 70(6):515-21. PubMed ID: 26242496
[TBL] [Abstract][Full Text] [Related]
18. [MEDICATIONS DEPRESCRIBING IN ELDERLY NURSING HOME RESIDENTS].
Aizen E; Hindawil E; Hijazi M; Merih A; Shahla H; Elyounes AA
Harefuah; 2016 Mar; 155(3):145-9, 197. PubMed ID: 27305746
[TBL] [Abstract][Full Text] [Related]
19. How confident are physicians in deprescribing for the elderly and what barriers prevent deprescribing?
Djatche L; Lee S; Singer D; Hegarty SE; Lombardi M; Maio V
J Clin Pharm Ther; 2018 Aug; 43(4):550-555. PubMed ID: 29682764
[TBL] [Abstract][Full Text] [Related]
20. Assessing medication burden and polypharmacy: finding the perfect measure.
Gnjidic D; Tinetti M; Allore HG
Expert Rev Clin Pharmacol; 2017 Apr; 10(4):345-347. PubMed ID: 28271722
[No Abstract] [Full Text] [Related]
[Next] [New Search]
